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The thesis belongs to the Triangle Hospital project in the Meilahti hospital area in the Hospi-
tal district of Helsinki and Uusimaa (HUS). One of the challenges in the new hospital was pa-
tient information and safe medication. Transdermal medication has shown to have clinical 
benefit and high-level patient acceptability. 
 
The purpose of this study was to describe the guidance of transdermal medications on pa-
tients who need chronic pain management on the bases of a literature review. The research 
question is: How is the guidance of transdermal medications described for patients who need 
chronic pain management on the bases of the literature review? 
 
The method of the review was qualitative research. Systematic literature review was used in 
data collection, and inductive qualitative content analysis was used in the interpretation of 
data. 
 
Two major categories were identified from the content of the data. The first category was 
staff and patient education in the administration of transdermal medications; the subcatego-
ries were indications for transdermal medication administration, planning its administration, 
assessment of the transdermal medication use, documentation of the administration, staff 
education for the administration and patient guidance of transdermal medication use. The 
second category was risks in the administration of transdermal medications; the subcategories 
were medication errors by patients in the use of transdermal medications, overdose and 
abuse of transdermal fentanyl, and prevention of medication errors by prescribers in admini-
stration of transdermal medication. The review of the literature revealed that there is a need 
for pain management that is easy for patients to use, gives continuous pain relief and has 
minimal side-effects. On the other hand transdermal route medication has the potential for 
patient harm if used inappropriately. It was also noted that there is not enough patient guid-
ance available. More research is required on safe administration and patient guidance of 
transdermal medications.  
 
Nurses are the front-line providers in patient education. They have the important role in re-
ducing errors by communicating and documenting the use of transdermal medication and by 
knowing the indications of the medication. Patient guidance could be developed further by 
developing a written form to be given to patients. The guidance could be about potency and 
dose of the medication, as well as the application, removal and disposal of the transdermal 
patch. 
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Opinnäytetyö kuuluu Kolmiosairaala -hankkeeseen Meilahden sairaala-alueella Helsingin ja 
Uudenmaan sairaanhoitopiirissä (HUS). Yksi uuden sairaalan haasteista oli potilastiedoitus ja 
turvallinen lääkitys. Lääkelaastarit ovat osoittautuneet kliinisesti sopiviksi ja potilaat ovat 
hyväksyneet ne yleisesti. 
 
Tämän opinnäytetyön tarkoitus oli kuvailla lääkelaastareiden käytön ohjausta potilailla, jotka 
tarvitsevat kroonisen kivun hallintaa systemaattisen kirjallisuuskatsauksen perusteella. 
Tutkimuskysymys oli: Miten lääkelaastareiden käytön ohjausta kuvaillaan potilailla, jotka 
tarvitsevat kroonisen kivun hallintaa systemaattisen kirjallisuuskatsauksen perusteella? 
 
Kirjallisuuskatsaus tehtiin laadullista tutkimusta käyttäen. Tiedonkeruu tehtiin systemaattisen 
kirjallisuuskatsauksen pohjalta ja sisällön analysointi tehtiin laadullisen induktiivisen sisällön 
analysoinnin avulla.  
 
Kaksi kategoriaa löytyi materiaalin sisällöstä. Ensimmäinen kategoria oli henkilökunnan ja 
potilaiden ohjaus lääkelaastareiden käytössä; alakategoriat olivat lääkelaastareiden käytön 
indikaatiot, lääkelaastareiden käytön suunnittelu, lääkelaastareiden käytön kirjaaminen, 
henkilökunnan kouluttaminen lääkelaastareiden käyttöön ja potilaiden ohjaus 
lääkelaastareiden käytössä. Toinen kategoria oli lääkelaastareiden käytön riskit; alakategoriat 
olivat potilaiden tekemät virheet lääkelaastareiden käytössä, fentanyl laastareiden 
yliannostus ja väärinkäyttö ja lääkelaastareiden määrääjien virheiden ehkäiseminen. 
Kirjallisuuskatsaus ilmaisee, että on olemassa tarve kivun hallintaan, joka on potilaille 
helppoa, antaa jatkuvaa kivun lievitystä ja jolla on minimaaliset sivuvaikutukset. Toisaalta 
lääkelaastarit aiheuttavat vahinkoa potilaille, jos niitä käytetään väärin. Ilmeni myös, että 
potilaille ei anneta tarpeeksi ohjausta lääkelaastareiden turvallisesta käytöstä. Turvallinen 
lääkelaastareiden käyttö ja potilaiden ohjaus vaativat vielä lisää tutukimustyötä. 
 
Sairaanhoitajat ovat etulinjassa potilaiden ohjauksessa. Heillä on tarkeä rooli virheiden 
vähentämisessä keskustelemalla ja kirjaamalla lääkelaastareiden käytön ja tietämällä 
lääkkeen indikaatiot. Potilasohjausta voisi kehittää edelleen luomalla kirjallista tiedoitusta 
potilaille. Ohjaus voisi sisältää tietoa lääkkeen vahvuudesta ja annostelusta, kuten myös 
lääkelaastarin asentamisesta, poistamisesta ja hävittämisestä. 
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1 Introduction 
 
The thesis belongs to the Triangle Hospital project in the Meilahti hospital area which is spe-
cialised for internal medicine with a total of 210 patient beds, out patient department and 
day hospital. The hospital was opened in 2010. The Triangle Hospital project is a part of 
HUS’s and Laurea University of Applied Sciences’ collaboration. One of the challenges in the 
new hospital is patient information and safe medication. The aim of the project is to develop 
guidance and information service in the Triangle Hospital. 
(www.laurea.fi/optima/hankefoorumi) 
 
In February 2010 there was a medical demonstrator visiting a hospital ward in Espoo. She 
introduced a new transdermal patch for the nursing staff. She told about Norspan (buprenor-
fin) 5 mcg, 10 mcg and 20 mcg. Norspan is good for long term pain management when 
paracetamol and anti-inflammatory drugs are not enough. One patch is applied every 7 days 
instead of 24 hours like in the case of the older types of patches. In the discussion afterwards 
the nurses pointed out some problems concerning the administration of transdermal patches 
in hospital environment. For example, they told about a case when a patient came to the 
hospital with several patches on the body and an other case when a nurse did not see a previ-
ous patch and applied a new one. The same problem areas would be considered in the ad-
ministration of transdermal route medications at home environment. 
 
A transdermal patch is a small, adhesive-backed patch that is attached to the skin. It contains 
a specific time-released medicine in a waterproof gel that passes through the epidermis into 
the blood vessels in the dermis. Epidermis is the outer layer of the skin. It contains no blood 
vessels, but most of it is so thin that even minor cuts reach the dermis and draw blood. Der-
mis is a strong, flexible connective tissue meshwork of collagenous, reticular, and elastic 
fibers. Blood vessels, lymphatic vessels, nerve endings, hair follicles, and glands are present 
in the dermis. Although the skin is almost waterproof and is solid enough to keep out the wa-
ter, it is also porous enough to allow some chemicals in; both harmful substances and thera-
peutic medicines. (Van Wynsberghe, Noback & Carola 1995, 133,138) 
 
“Transdermal patches are polymeric formulations which when applied to skin deliver the drug 
at a predetermined rate across dermis to achieve systemic effects. Transdermal dosage 
forms, though a costly alternative to conventional formulations, are becoming popular be-
cause of their unique advantages. Controlled absorption, more uniform plasma levels, im-
proved bioavailability, reduced side-effects, painless and simple application and flexibility of 
terminating drug administration by simply removing the patch from the skin are some of the 
potential advantages of transdermal drug delivery” (Aggarwal, 2009).
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The principle conclusions suggested by the results are that there is a need for pain manage-
ment that is easy for patients to use, give continuous pain relief and has minimal side-effects. 
Transdermal route medication has clinical benefit and high–level patient acceptability. But it 
has the potential for significant patient harm if used inappropriately. Nurses are the front-
line providers in patient guidance and safety. The misuse of transdermal medications have 
resulted in medication errors and abuse of the medications. Transdermal route medications 
can also be prescribed inappropriately (Cranwell-Bruce 2007, 333 and Grissinger 2010,  
653) 
 
2 Purpose of the study and research question 
 
The purpose of the thesis is to describe the guidance of transdermal route medications for 
patients who need chronic pain management on the bases of the literature review. One of the 
visions of Triangle Hospital is to support patient’s participation in his/her own active care. On 
the other hand one of the challenges in the new hospital is patient information and safe 
medication. The pertinent literature concerning transdermal route medications is reviewed in 
Appendices Tables 3 and 4. 
 
The research question is: How is the guidance of transdermal route medications described for 
patients who need chronic pain management on the bases of the literature review?  
 
The method of the study is qualitative research. Systematic literature review is used in data 
collection, and qualitative content analysis is used in the interpretation of data. 
 
 
3 Systematic literature review 
 
The research method in this study was qualitative approach which consist an investigation 
that seeks answers to the research question. Qualitative research aims to gather an in-depth 
understanding of human behaviour and the reasons that influence such behaviour. Scharalda 
& Leonard (2010, 613) write that qualitative research methods are usually used when little is 
known about the topic. It allows the researcher to explore the topic; the meanings and inter-
pretations can be explored. 
 
Systematic literature review is research that summarizes the evidence on a clearly formu-
lated question using systematic and explicit methods to identify, select and appraise relevant 
studies, and to extract, collate and report their findings. (Khan, Kunz, Kleijnen & Antes 2003, 
132) Systematic literature review was used in the data collection in this study. Literature 
search was systematic search of published articles, journals and research reports that were 
relevant to the thesis. According to Silverman (2000, 226-231) literature review combines 
knowledge and critical thought. Literature review can be defined as a selection of available 
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documents on the topic, which are information, ideas, data and evidence written from a par-
ticular standpoint to fulfil certain aims or express certain views. Literature review gives an-
swers about what is already known about the topic, where does this work fit in what has been 
done before, and why this research worth doing in the light of what is has already been done. 
 
Systematic literature review can be divided into three parts. First part includes the planning 
phase of the review. 1-3 clear research questions appear in the plan. After the research ques-
tions have been set the methodology of the review is chosen. The methodology includes the 
selection of the databases and research terms. In the second phase the data is screened and 
the relevant articles are chosen. The included articles are analysed considering the criteria 
for inclusion and exclusion. In the last phase the data of the study is analysed and the conclu-
sions and possible recommendations are done in the discussion of the review. (Johansson, 
Axelin, Stolt & Ääri, 2007, 5-7) 
 
The reason why qualitative research was chosen as a method for this thesis was to understand 
how and why the findings were achieved not only what was achieved. Literature review as a 
method allowed the reader to become updated with current knowledge on the topic. It also 
gave a basis for possible future research. 
 
3.1 Data 
 
The databases were selected from publications of health journals. The process includes lit-
erature search, screening and selection of data, and data analysis. The databases used in this 
study were: EBSCO (CINAHL), EBSCO (Academic Search Elite), Elsevier Science Direct, Ovid 
(Medline), Medic and Pubmed. 
 
3.1.1 Data screening and selection 
 
At step 1 (Figure 1) the titles and/or abstracts were analysed for relevance of the study ac-
cording to the research task. In the search the operators OR and AND were used, and the 
terms were” Pain management”, “Transdermal route medication”, “Patient education” and 
“Transdermal patch” .  The first search combining “Pain management” OR “Transdermal 
route medication” retrieved all citations where either one or both terms were found. The 
citation set was too large with combined result of 102 348 hits. After several sets of terms the 
search term combination “Transdermal patch” AND “”Patient education” turned out to be the 
most useful. The number of search results was manageable and they were from most of the 
selected databases. The combined result for the search was 120 potential articles, but only 
10 of the articles were included in the literature review (Table 1). The 10 articles were saved 
in “Nelli” and they were also printed to allow closer reading and inspection. 
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At step 2 (Figure 1) the titles and/or abstracts of the 120 potential articles were studied care-
fully. The inclusion and exclusion criteria were applied (Table 2). The study selection criteria 
were that the searched material was relevant to the research task, and that the full text arti-
cles were available. Time limitation of the year of the publication was not used because the 
number of relevant articles was limited. Nevertheless all the pertinent articles considering 
transdermal medications were published during the last ten years. The articles in other than 
English language were excluded. The articles had to be about pain management. Many arti-
cles had information about other forms of medications like nicotine, hormone replacement 
therapy and glycerol trinitrate in the prophylaxis of angina. After the data screening ten arti-
cles were included in the literature review. The significance of the articles for this literature 
review was assessed. The articles were summarised narratively and thematically. The in-
cluded 10 articles are listed in Appendices in Tables 3 and 4. The significance of the 10 arti-
cles for this literature review was narrated. The articles were listed in the order of the sig-
nificance, not in the alphabetical order. In most of the included articles “transdermal patch” 
was used instead of “transdermal route medication”. For that reason the term “Transdermal 
patch” was used in the search. “Patient education” turned out to be more used term than 
“patient guidance”. In the text of the literature review the terms “transdermal medication” 
and “transdermal patch”; “patient education” and “patient guidance” were used collaterally. 
 
Database ”Pain man-
agement” 
OR 
”Transdermal 
route medica-
tion” 
“Transdermal 
route medi-
cation” 
AND 
“Patient edu-
cation” 
“Transdermal 
patch” 
AND 
“Patient edu-
cation” 
AND 
“Pain man-
agement” 
“Transdermal 
patch” 
AND 
“Pain man-
agement” 
“Transdermal 
patch” 
AND 
“Patient edu-
cation” 
EBSCO 
(CINAHL) 
41617 0 0 7 12 
EBSCO 
(Academic 
Search 
Elite) 
10517 0 11 54 27 
Elsevier 
Science 
Direct 
25479 0 15 238 68 
Ovid  
(MEDLINE) 
8531 0 0 5 6 
Medic 
 
4 0 0 0 0 
Pubmed 
 
16200 33 0 5 7 
Combined  
results 
102348 33 26 309 120 
 
 
Table 1: Table 1 shows the literature search results with the number of hits using five differ-
ent sets of terms. 
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Inclusion Exclusion 
Studies that were relevant to the research 
task 
Studies that were not relevant to the re-
search task 
Studies that were available in full text 
 
Studies that were not available in full text 
Studies in English 
 
Studies not in English 
 
Table 2: Inclusion and Exclusion criteria 
 
 
 
 
3.2 Data analysis 
 
The types of data were published articles, journals and research reports. Qualitative content 
analysis method was used in the interpretation of data. Flick (2002, 190) writes that content 
analysis is one of the classical procedures for analysing text. One of the essential materials is 
the use of categories, and the goal is to reduce the material. According to Silverman in quali-
tative research the aim is to understand categories. The researchers are more concerned with 
the processes through which texts depict ‘reality’ than with whether such texts contain true 
or false statements. Data analysis consists of three concurrent flows of activity. Data reduc-
tion is the process of selecting, focusing, simplifying, abstracting and transforming data. Data 
display is an organized assembly of information that permits conclusion drawing (Silverman 
2000, 128-142). 
After the abstracts and findings of the potential articles were screened, the 10 articles which 
fulfilled the inclusion criteria (Table 2) were included in the literature review. At step 3 (Fig-
ure1) the data was analyzed by listing the relevant sentences. The method was induction 
which moved from the specific information to the general forming larger categories. After 
listing the content of the included ten articles, the content was categorized under titles so 
that the categories included similar factors. Two major categories were identified from the 
content: Staff and patient guidance in the administration of transdermal medications and 
Risks in the administration of transdermal medications. At step 4 (Figure 1) the findings of the 
included 10 articles were interpreted and categorized under the sub-categories in Findings of 
the study. 
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Figure 1: Shows the step-by-step explanation of the process for writing the literature review. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 1 
 
Identifying relevant literature accord-
ing to the research task. 
Step 2 
 
Reading and coding the literature, and 
choosing ten relevant articles. 
Assessing significance of the articles. 
 
Step 3 
 
Analysing the data of the articles by 
listing the relevant sentences and 
categorizing the content under titles. 
 
Step 4 
 
Interpreting the findings of the rele-
vant content in the categories. 
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4 Findings of the study 
 
4.1 Staff and patient education in the administration of transdermal medications 
 
4.1.1 Indications for transdermal medication administration 
 
It was noted in the literature that pain was one of the most important issues in health care. It 
was also noted that every year over 50 million people experienced chronic pain. Pain ac-
counted for more disability than cancer and heart disease and accounted over $ 60 billion in 
lost productivity each year. Poor management of pain was linked to reduced patient satisfac-
tion, increased economic burden, and reflected in the length of hospital stay and number of 
readmissions for the treatment of uncontrolled pain. It was noted as well that there was a 
need for pain management methods that were easy for patients to use, gave continuous pain 
relief, and had minimal side-effects. 
 
Transdermal administration of medication was becoming a useful alternative to oral medica-
tion. Potent opioid in fentanyl patch was intended for time-released transdermal medication 
delivery. Fentanyl in a transdermal patch released medication slowly over a 72 –hour period 
to manage chronic moderate-to severe pain. Transdermal patches allowed the medication to 
be continuously absorbed through the skin and into the systemic circulation. Also buprenor-
phine was studied in a transdermal delivery system for management of severe cancer pain 
and chronic non-cancer pain. Buprenorphine was an attractive first-choice opioid for the 
treatment of acute and chronic pain, it was a partial mu receptor agonist. Buprenorphine was 
available in parenteral, sublingual tablets, sublingual solution and transdermal formulations. 
Buprenorphine therapy could be used for chronic noncancer pain like osteoarthritis pain. 
 
4.1.2 Planning the transdermal medication administration 
 
When gathering a medication history a nurse’s questions may make a big difference with re-
gard to whether transdermal patched were discovered. It was important to communicate and 
document the use of patches. The nurses took a detailed medication history including aller-
gies, adverse effects and side-effects of past medications. Asking which medication worked or 
did not work in the past was important.  
 
Nurses also provided adequate patient education by taking a careful history, which could help 
to prevent many problems with medications. It was also important to become familiar with 
the different doses available and nomenclature issues (a system of names). When patients 
had patches which contain traces of metal there was the potential for serious burns when 
they underwent magnetic resonance imaging (MRI): it was recommended to remove the patch 
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prior MRI. It was helpful to have a list of transdermal patches that were known to contain 
metal. 
 
It was noted that in terminal care good pain control needed effective dosing and careful 
choice of analgesic, and awareness of the importance of changing disease. It was also noted 
that there was a need to actively involve both patients and carers in the management of 
symptoms. Transdermal analgesia was an effective method of analgesic delivery where the 
patient’s pain was stable and opioid responsive. It was especially useful when there were 
side-effects to oral morphine, when the patient was unable to swallow or in situations where 
the administration of medication was unreliable. Although controlled-release medications had 
positive effects on patients, such as improved sleep, ability to participate in rehabilitation 
and enhanced pain management, their longer half-life means more toxicity in overdoses. A 
review of the literature revealed multiple problems with overdose and abuse since the fen-
tanyl patch became available. 
 
4.1.3 Assessment of the transdermal medication use 
 
Pain became known as “the 5th vital sign”. To rate the pain level became a routine part of 
assessment. It was noted that performing a complete skin assessment prior applying a trans-
dermal opiate and to question the patients if they had a patch before was a good rule to per-
form. It was also important to assess the concomitant use of opioids. Health care practitio-
ners should recognize the signs of fentanyl overdose – respiratory distress; shallow breathing; 
tiredness, extreme sleepiness, or sedation; an inability to think, talk, or walk normally; and 
feeling faint, dizzy, or confused. 
 
Patients with life-limiting illness experienced symptoms that could cause discomfort and dis-
tress. Awareness of the importance of advancing or changing disease was needed, and that 
good pain control needed adequate assessment and regular review. About half of the patients 
who had cancer pain experienced pain that was inadequately controlled. Inadequate pain 
assessment, under-dosing of medication, failure to educate and monitor patients, and failure 
of the medication to relieve pain were likely to cause distress. 
 
4.1.4 Documentation of the transdermal medication administration 
 
In many facilities the application including location and the removal of the patch were docu-
mented onto the medication administration record (MAR). A new clinical practice process was 
initiated to improve medication administration record documentation to ensure patient 
safety. The process included all transdermal patch preparations. MAR had an entry were 
nurses can document the location of the patch, time of administration, and when the next 
14 
 
patch was due. The integrity and adhesion of the patch were checked and documented during 
each shift in MAR. 
 
4.1.5 Staff education for the transdermal medication administration 
 
The Food and Drug Administration in the USA issued a Public Health Advisory in 2005 warning 
practitioners to use safety information sheets and teach patient precautions, including signs 
and symptoms of overdose, techniques for applying the patches, and use of other medications 
while using the patches. 
 
Nurses can reduce errors by routinely asking patients if they had a patch. Asking about trans-
dermal patches is as important as asking about over-the-counter medications. Communicating 
and documenting the use of patches, removing patches containing metal prior to use of MRI, 
carefully discarding used patches, and educating patients about the safe use at home also 
reduce medication errors. 
 
Health care practitioners needed to be aware that many transdermal patches often had a 
significant amount of active medication remaining after removal. Therefore appropriate dis-
posal of the patch was important. Staff was educated to fold transdermal patches onto them-
selves and disposing them in protected sharp containers. In order to promote medication 
safety mandatory patient education could be beneficial – to show how to use the patch 
safely, discussion about the medication’s indications: potency, dose, safety, application, re-
moval, disposal, and signs of toxicity; avoiding heating pads or hot tubs; and removing the old 
patch before applying a new one. Because there was no common size or shape to the trans-
dermal patch design, and the overlays were clear or skin-toned, the products can be very 
difficult to see. Besides many patches also had different instructions for placement and sug-
gest rotation on the skin. 
 
A patient may have a fear of becoming addicted to the medication. It was noted that fear of 
addiction may result in undertreatment of pain. Nurses should know that only a small per-
centage of patients actually became addicted. 
 
4.1.6 Patient guidance of transdermal medication use 
 
Nurses were the front line providers in patient education and safety. They can assist patients 
in correct use of opioid medications. The nurses can educate them about home safety espe-
cially related to storage of the medication. Nurses can also teach about addiction potential 
and adverse effects. They should make sure that the patients were aware that any vasodila-
tion and vascularization in the patch area influenced absorption of the medication. For exam-
ple, a heating pad or hot water bottle over the patch increased the rate of medication ab-
sorption. Most commonly patients were advised to place the patch on the torso or trunk of 
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the body between the neck and the waistline, to scrotal tissue, or the skin behind the ear or 
the upper arm, and that the patch was applied to clean, dry and hairless skin. 
 
Patient precautions included signs and symptoms of overdose, techniques for applying the 
patches, and use of other mediations while using the transdermal patches. Patches should not 
be flushed into the public sewer system because there was a risk for havoc in the plumbing, 
sanctioned as a safe disposal method by the Environmental Protection Agency in the USA. 
 
4.2 Risks in the administration of transdermal medications 
 
4.2.1 Medication errors by patients in use of transdermal medications 
 
All transdermal patches had the potential for significant harm if used inappropriately. In the 
articles several cases were mentioned about medication errors. For example, while a nurse 
took the medication history of a patient who was admitted to the hospital, the patient ne-
glected to mention the fentanyl patch that she was wearing. A physician ordered fentanyl 
with additional morphine. The result was an overdose of fentanyl. In another case, upon ad-
mission assessment four nitroglycerine patches were discovered on the patient on top of one 
other and the previous patches were not removed. The caregiver did not understand that the 
patch must be applied directly to the skin to be effective. There were reports of patients who 
applied the adhesive overly without first applying the patch containing the medication. An 
overdose can also take place when a patient put fentanyl patches on the skin “wherever it 
hurt” – the patient had applied six fentanyl patches in all. In a similar event, patient died 
when his wife applied six fentanyl patches to his skin all at once, failing to remove older 
patches. It was also noted about a patient who placed the patch on the skin with adhesive 
tape but never removed the protective paper or plastic. The result was that the patient be-
came underdosed. 
 
A trend related to transdermal patch administration of fentanyl was noticed. Adverse reac-
tions were reported in patients whose fentanyl patches fell of with an unknown duration of 
therapy, the result was that patients experienced opioid withdrawal. Some patients were 
found with multiple expired patched that were placed on different days. 
 
4.2.2 Overdose and abuse of transdermal fentanyl 
 
Multiple headlines in resent years identified the dangers of opiate abuse and deaths from 
overdoses. Fentanyl patch was intended for opiate-treated, opiate tolerant patients with 
significant chronic pain. Overdose of a fentanyl patch occurred if the patient used more then 
the prescribed dose, if body temperature reached 40 degree, or the patient’s skin was ex-
posed to a direct heat sources. Abuses include patients extracting medication from the patch 
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then injecting or swallowing it, applying multiple patches or mixing the extracted medication 
with heroin. In abuse situations the medication was delivered by intravenous injection of 
patch contents, oral or transmucosal application. In order to enhance and hasten medication 
absorption heat was applied to the patch. Medication can also be delivered by volatilization 
and inhaled of the steam and/or consumption of the liquid. 
 
Most of the fentanyl overdose victims die from the direct toxic effects. An uncommon misuse 
of a patch was mentioned: chewing and followed by complications of aspiration of the patch 
in combination with other illicit drugs caused death. Fentanyl was rapidly absorbed orally 
because the oral mucosa was thin and non-keratinized. 
 
Individuals who abused prescription medications may modify the route of administration from 
the intended method in order to obtain a more rapid “high”. The desired effect of achieving 
euphoria from a sustained-release product such as fentanyl patch required just such modifica-
tion, because the intended delivery was very slow. Method such as chewing was particularly 
dangerous as they mechanically disrupted the patch, unleashing a full dose in a short period 
of time. An example of an accidental ingestion was fatal fentanyl intoxication after the inges-
tion of a patch by a 1-year-old child. 
 
4.2.3 Prevention of medication errors by prescribers in administration of transdermal medi-
cation 
 
Specific prescribing and dispensing guidelines should be developed for prescribers or pharma-
cists. Fentanyl patches should only be for patients who were opioid-tolerant, with chronic 
pain, not well controlled with shorter-acting analgesics. Equianalgesic conversion tables could 
be used to help in changing doses. 
 
The pharmacist should determine the medication’s indication in order to ensure that patient 
was opioid-tolerant and had chronic pain. The pharmacist should question the order if the 
patient is opioid-naïve or the patch was intended to treat short-term, intermittent or post-
operative pain. 
 
Setting dosing limits could prevent medication errors. The patch should be prescribed at the 
lowest dose needed. No more than 25 mcg/hour of fentanyl should be prescribed as a first-
time dose. Prescribers should also take into consideration any other opioids that have been 
ordered for the patient. Finally, it was noted that it could be prudent to restrict the prescrib-
ing of fentanyl patches by limiting prescribing privileges only for prescribers who were edu-
cated about the medications. 
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Safe administration of transdermal medications 
 
 
 
 
 
 
Figure 2: Shows the findings of the study. 
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5 Discussion 
 
5.1 Ethics and trustworthiness 
 
Researches are unconditionally responsible for the honesty of the research process. The 
power to produce knowledge requires responsibility for honesty in the production. (O’Leary, 
2004, 50) 
 
The German sociologist Max Weber pointed out that all research is contaminated to some 
extend by the values of the researcher. Only through those values do certain problems get 
identified and studied in particular ways. The conclusions and implications to be drawn from 
a study are largely grounded in the moral and political beliefs of the researcher. (Silverman, 
2000, 200)  
According to Silverman (2000, 201) ethical dilemmas can be avoided by deciding what is the 
purpose of the research, examining which individuals or groups might be interested or af-
fected by the research, and considering what are the implications for these parties of framing 
the research topic in the way it is done.  
 
Trustworthiness is an essential component of qualitative research. Findings should reflect the 
reality of the experience. In qualitative research four issues of trustworthiness demand atten-
tion: credibility, transferability, dependability, and conformability. “Credibility is an evalua-
tion of whether or not the research findings represent a credible conceptual interpretation of 
the data drawn from the participants’ original data. Transferability is the degree to which the 
findings of this inquiry can apply or transfer beyond the bounds of the project. Dependability 
is an assessment of the quality of the integrated processes of data collection, data analysis, 
and theory generation. Conformability is a measure of how well the inquiry’s findings are 
supported by the data collected”. (Lincoln & Guba, 1985, 296) 
 
The data in this thesis comes from medical journals. The articles have been critiqued and 
reviewed before publication. Therefore the data which was collected for the literature re-
view can be seen trusted. Ethical considerations were taken into account by accurately ana-
lyzing and reporting the findings of selected articles avoiding bias as much as possible. Refer-
ences from the included articles were reported in the text and the list of references was done 
accurately according to Laurea’s thesis guidelines. The principle of transparency was consid-
ered by showing the steps of the process for writing the literature review. 
 
Many of the articles which related to the subject and which were from the selected databases 
were not full text article. One of the limitations for this systematic literature review also was 
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that the sample of included articles was small to allow generalization of the subject. A limi-
tation of the review was that only two of the articles described nurses’ safe practice recom-
mendations about use of transdermal medications. The same articles had patient education 
mentioned but sufficient details were missing (Paparella, 2005 and Grissinger, 2010). One 
article emphasizes the role of a nurse in patient education (Cranwell-Brice, 2007), and an-
other  one  describes  the  role  of  a  pharmacist  (Fan  & Elgourt,  2008).  Carson,  Knight  &  Garg  
wrote  about  abuse  of  transdermal  patches  but  there  was  nothing  about  patient  educa-
tion/guidance. 
 
5.2 Discussion of the findings 
 
According to Safe pharmacotherapy (Publications of the Ministry of Social Affairs and Health 
2009, 41-46) the pharmacotherapy plan is required to cover the pharmaceutical services. The 
plan also takes account of the role of pharmaceutical services in the guidance and informa-
tion on medicines. The national guide provides plan for distribution and administration of 
medicine, patient information and advice, evaluating treatment effectiveness, documenta-
tion and information, and monitoring and feedback systems. Safe administration of the trans-
dermal patch requires the general guidelines and principles for pharmacotherapy. 
 
Grissinger (2010, 654) points out that fentanyl transdermal patches are still prescribed inap-
propriately to treat acute pain. He writes about proper prescribing of fentanyl patches in 
form of safe practice recommendations. Grissinger (2010, 653) also writes that fentanyl 
transdermal patches are sometimes prescribed inappropriately to treat acute pain in patients 
who are not opioid-tolerant. The medication is sometimes prescribed in large doses or in 
combination with oral or intravenous opioids. Pharmacists have filled fentanyl patch prescrip-
tions without questioning if the dose was correct, and the nurses have applied the patches to 
patients without recognizing possible prescribing errors. 
 
The nurses are the front-line providers in patient guidance and medication safety. The find-
ings of this literature review are significant in order to point out the important role of the 
nurses in medication administration including transdermal medications. The nurses are able 
to reduce errors by communicating and documenting the use of transdermal patches, by be-
coming familiar with different medications and doses; application, removal and disposal of 
the patches, and by knowing the signs of toxicity and overdose of transdermal medications. 
(Paparella 2005, 280) 
 
 
The findings of this systematic literature review points out that there is a relationship be-
tween prescription and administration of transdermal medication. Nurses must be sure that 
the medication that they are administering is prescribed correctly. They must take the care-
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ful medication history, communicate and document the usage of all the medications of cur-
rent use and become familiar with indications of medications. The nurses should also provide 
the patients with accurate and comprehensive guidance about how to use transdermal medi-
cations in a safe manner; how to apply the patch, and how to store and dispose it in order to 
prevent misuse and abuse. 
 
A practical application for the safe administration of transdermal medications is that all the 
patients with this kind of medication should receive education both in practice and in written 
form: about potency and dose of the medication; application, removal and disposal of the 
patch; and signs of toxicity and overdose. The practical guidance could include showing a 
patient how to take off the covering foil and protective plastic, and how to apply the patch 
on clean, hairless and dry skin. As well as telling about the principles about rotation of the 
site, and the ideal locations on the body for the patch. They should get a telephone number 
in case of uncertainty or problems concerning the use of transdermal medications in chronic 
pain management. There could be a ready printed form in each ward with the pertinent in-
formation to be given to patients with transdermal medication. 
 
Because transdermal administration of medication is rapidly becoming a useful alternative to 
oral medication administration and serious errors continue to occur, there is an urgent need 
for further research for safe administration of transdermal medications. In order to be able to 
educate patients about safe medication the nurses must know the principles of appropriate 
prescribing and proper administration of transdermal patches.  
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Appendices 
 
Appendix 1 Table 3 
Author and the 
year of the 
publication 
Name of publi-
cation 
Purpose of  
the study 
Design of the 
study 
Findings/ 
Significance to this 
study 
Paparella Susan 
2005 
Transdermal 
patches: An 
unseen risk for 
harm 
To point out how 
nurses can re-
duce the misuse 
of transdermal 
medications 
A column based 
on reports from 
the Institute 
for Safe Medi-
cation Prac-
tices (ISMP) 
The safe practice 
recommendations 
for nurses how to 
reduce transder-
mal medication 
errors/The infor-
mation in the col-
umn is significant 
for this study 
Grissinger Mat-
thew 
2010 
Inappropriate 
prescribing of 
fentanyl 
patches is still 
causing alarm-
ing safety prob-
lems 
To point out the 
need for safe 
practice recom-
mendations for 
fentanyl trans-
dermal patch 
prescriptions 
A column based 
on reports from 
the ISMP Medi-
cation Errors 
Reporting Pro-
gram (MERP) 
The safe practice 
recommendations 
help avoid the risk 
of harm caused by 
prescribing er-
rors/The informa-
tion in the column 
is significant for 
this study 
Cranwell-Bruce 
Lisa 
2007 
Update on pain 
management: 
New methods of 
opiate delivery 
To point out the 
importance of 
nurses role in 
patient educa-
tion and safety 
for different 
forms of medica-
tions including 
transdermal 
medications 
A literature 
review 
The study gives 
information about 
correct admini-
stration of the 
various forms of 
opioid meds in-
cluding transder-
mal medica-
tions/There is 
significance to this 
study 
Fan Teresa and 
Elgourt Tanya 
2008 
Pain manage-
ment pharmacy 
service in a 
community 
hospital 
The implementa-
tion of a pain 
management 
pharmacy service 
in a community 
hospital 
A case study The study is about 
a role of a pain 
management 
pharmacist/There 
is a partial signifi-
cance to this study 
Carson Henry, 
Knight Laura, 
Dudley Mary 
and Garg Uttam 
2010 
A fatality in-
volving an un-
usual route of 
fentanyl deliv-
ery: chewing 
and aspiring the 
transdermal 
patch 
To report about 
an abuse of 
opioid transder-
mal patch by oral 
ingestion 
A case report  The report gives 
information about 
one transdermal 
patch abuse 
case/There is par-
tial significance to 
this study 
 
 
Table 3: Review of articles where search term combination” Transdermal patch” AND ”Pa-
tient education” is used. 
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Appendix 2 Table 4 
Author and the 
year of the 
publication 
Name of publi-
cation 
Purpose of  
the study 
Design of the 
study 
Findings/ 
Significance to 
this study 
Zinn Linda 
2003 
Consultant 
pharmacists: 
Saving lives and 
money 
To find out how 
to assist long 
term care or-
ganizations with 
drug therapy 
Interview with 
Steve Feldman 
RPh 
Appropriate 
medication use 
in the elderly 
can improve 
quality and 
quantity of 
life/Limited 
significance to 
this study 
Russo Marc and 
Wasiak Jason 
2007 
A clinical snap-
shot of trans-
dermal bupre-
norphine in pain 
management 
To point out 
that transder-
mal patches 
have shown to 
have clinical 
benefit 
A literature 
review 
Transdermal 
patches give 
high-level pa-
tient acceptabil-
ity compliance 
and improved 
quality of 
life/Limited 
significance 
Borchgrevink 
Petter 
2010 
Long-term low-
dose transder-
mal buprenor-
phine therapy 
for chronic non-
cancer pain 
To compare low 
dose transder-
mal buprenor-
phine with pla-
cebo patched 
for osteoarthri-
tis pain 
A double blind 
placebo-
controlled study 
Documentation 
of the possibility 
to perform a 
high-quality 
randomized 
control trial 
during a time 
period that is 
long enough to 
give meaningful 
data/Limited 
significance 
Lawrie Iain and 
Simpson Karen 
2007 
 
Management of 
pain in the ter-
minally ill 
How to provide 
good pain con-
trol in patients 
with advanced 
illness 
Feature article Effective pain 
control requires 
active multidis-
ciplinary total 
management 
with regular 
review and 
timely reassess-
ment/Limited 
significance 
Bennett Michael 
2005 
Management of 
severe pain in 
terminal care 
To point out 
importance of 
proper assess-
ment of patients 
with cancer pain 
Feature article Management of 
new pain re-
quires assess-
ment of the 
cause and 
treatment of 
cancer-related 
pain/Limited 
significance 
 
Table 4: Review of articles where search term combination ”Transdermal patch” AND “Pain 
management” are used. 
 
